Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer
- PMID: 16935973
- PMCID: PMC1860484
- DOI: 10.1136/jcp.2005.035394
Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer
Abstract
Aim: To establish independent prognostic factors on a chromosomal basis in superficial bladder cancer, using a multicolour fluorescence in situ hybridisation (FISH) probe mix.
Patients and methods: In 2002, voided urine from 75 consecutive patients (mean age 71.7, range 52-93) years under follow-up for superficial urothelial cancer was studied prospectively. The patients were observed for a mean (standard deviation (SD)) period of 39.3 (6.8) months (range 27-58) until July 2005. A multicolour FISH on liquid-based voided urinary cytology was carried out on all patients. Univariate analysis, using a log rank test, was used to determine the prognostic relevance of a low-risk pattern and a high-risk pattern. Progression-free survival time was calculated from the date of first diagnosis to first recurrence or progression according to the Kaplan-Meier product-limit method.
Results: One patient was lost to follow-up. 27 of the 74 remaining (36.8%) patients showed recurrent disease. In 9 (33.3%) patients with a low-risk pattern disease recurred after a mean (SD) observation time of 29.7 (1.9) months (range 8.3-52.3, median 30.8 (12.4)). 18 (66.7%) patients with a high-risk pattern developed recurrence within a mean (SD) of 17.6 (2.0) months (range 4-38.8, median 16.7 (11.6)). The Kaplan-Meier curve for progression-free survival showed marked differences between the low-risk and the high-risk groups.
Conclusion: Patients with a high-risk chromosomal pattern have a markedly shorter disease-free survival time and higher progression rate than patients with a low-risk pattern. High-risk patients can therefore be treated more aggressively to prevent tumour spreading.
Conflict of interest statement
Competing interests: None.
References
-
- Chopin D K, Gattengo B. Superficial bladder tumors. Eur Urol 200242533–541. - PubMed
-
- Soloway M S. Managing superficial bladder cancer: an overview. Urology 1992405–10. - PubMed
-
- Lutzeyer W, Rübben H, Dahm H. Prognostic parameters in superficial bladder cancer. An analysis of of 315 cases. J Urol 1982127250–252. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical